Dr. Yoho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1255 Ashby St
Ste A
Seguin, TX 78155Phone+1 830-590-8049Fax+1 806-771-2093
Summary
- Dr. Jason Yoho is a cardiologist in New Braunfels, TX and is affiliated with multiple hospitals in the area, including Guadalupe Regional Medical Center and Resolute Health. He received his medical degree from West Virginia University School of Medicine and has been in practice 15 years. He specializes in interventional cardiology, peripheral endovascular interventional cardiology, vascular medicine, and cardiac critical care and is experienced in cardiac catheterization, peripheral vascular disease, cardiac critical care, critical care medicine, and peripheral endovascular interventional cardiology.
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Interventional Cardiology, 2009 - 2010
- University of Texas Health Science Center at HoustonFellowship, Cardiovascular Disease, 2006 - 2009
- Johns Hopkins UniversityChief Residency, Internal Medicine, 2005 - 2006
- Johns Hopkins UniversityResidency, Internal Medicine, 2002 - 2005
- West Virginia University School of MedicineClass of 2002
- University of MiamiBS, Psychobiology, Honors, 1993 - 1997
Certifications & Licensure
- TX State Medical License 2010 - 2026
- AL State Medical License 2010 - 2013
- CT State Medical License 2012 - 2012
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Chief Resident, Johns Hopkins University / Sinai Hospital
- Chief Fellow, University of Texas at Houston
Clinical Trials
- Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis Start of enrollment: 2011 Jun 01
- LEVANT 2 Safety Registry Start of enrollment: 2011 Jul 20
- Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- 453 citationsClopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study.Paul A. Gurbel, Kevin P. Bliden, Waiel M. Samara, Jason A. Yoho, Kevin Hayes
Journal of the American College of Cardiology. 2005-11-15 - 290 citationsThe Relation of Dosing to Clopidogrel Responsiveness and the Incidence of High Post-Treatment Platelet Aggregation in Patients Undergoing Coronary StentingPaul A. Gurbel, Kevin P. Bliden, Kevin Hayes, Jason A. Yoho, William R. Herzog
Journal of the American College of Cardiology. 2005-05-03 - 282 citationsClopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets: Results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets...Paul A. Gurbel, Kevin P. Bliden, Kazi A. Zaman, Jason A. Yoho, Kevin Hayes
Circulation. 2005-03-08
Press Mentions
- Vesper Medical Announces First Enrollment in the VIVID TrialDecember 1st, 2020
- AngioDynamics Announces First Patient Enrolled in PATHFINDER I Registry Examining Long-Term Effectiveness and Safety of Auryon Atherectomy SystemAugust 17th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: